Advertisement
Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Litvan, I.
Right arrow Articles by Hutton, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Litvan, I.
Right arrow Articles by Hutton, M.
Related Collections
Right arrow All Movement Disorders
Neurology 2001;57:138-140
© 2001 American Academy of Neurology
Brief Communications

Tau genotype: No effect on onset, symptom severity, or survival in progressive supranuclear palsy

Irene Litvan, MD;, Matt Baker, BSc; and Michael Hutton, PhD

From the Cognitive Neuropharmacology Unit (Dr. Litvan), Henry Jackson Foundation; and the Birdsall Research Building (Dr. Hutton and M. Baker), Mayo Clinic Jacksonville, FL.

Address correspondence and reprint requests to Dr. Irene Litvan, Cognitive Neuropharmacology Unit, Henry M. Jackson Foundation, The Champlain Building, 6410 Rockledge Drive, Suite 600, Bethesda, MD 20817-1844; e-mail: ilitvan{at}dvhip.org

Genetic studies have shown that progressive supranuclear palsy (PSP) is associated with inheritance of a specific genotype (H1/H1) in the tau gene. The authors investigated whether the H1/H1 genotype or A0/A0 genotype independently or in conjunction with selected environmental risk factors influences the age at onset, severity, or survival in patients with PSP. Our findings suggest that tau genotyping does not predict the prognosis of PSP.




This article has been cited by other articles:


Home page
 Mol. Pathol.Home page
K Tawana and D B Ramsden
Progressive supranuclear palsy
Mol. Pathol., December 1, 2001; 54(6): 427 - 434.
[Abstract] [Full Text] [PDF]


Advertisement